Matthew Herder and colleagues critically analyze the basis upon which Health Canada approved OxyContin.

In this posted letter, Matthew Herder explains his reasons for resigning from the Patented Prices Review Board on Mon. 20 Feb 2023.

Matthew Herder and colleagues critically review the regulatory history of buprenorphine formulations in Canada.

Matthew Herder and colleagues publish on the topic of fair pricing and Canada's orphan drug policy.

Françoise Baylis is interviewed by "Podcast or Perish" host Cameron Graham about her work generally, and on the ethics of gene editing specifically.

IDEAS speaks to world-leading bioethicist Françoise Baylis, a recent winner of the 2022 Canada Council Killam Prize for her influential work.

PHRI’s Executive Director Salim Yusuf joins his fellow 2022 Killam Prize winners (Françoise Baylis, Jeff Dahn, Carl E. James) in a panel discussion about research in Canada.

Françoise Baylis and Jeff Dahn—Two of Dalhousie’s leading researchers are being honoured with the $100,000 Killam Prize, winning two of the five prestigious awards granted annually by the Killam Trusts.

Françoise Baylis is a philosopher with an international reputation for her work in applied ethics at the intersection of theory and practice.

Françoise Baylis answers callers' questions on the topic of how to end the pandemic.